New York, NY, United States of America

Li Chin Wong

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Prevail Therapeutics, Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Chin Wong. Retrieved from https://idiyas.com/inventor/li-chin-wong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Li Chin Wong in Gene Therapy

Introduction

Li Chin Wong is a notable inventor based in New York, NY, whose groundbreaking work has made significant strides in the field of gene therapy. With a focus on treating lysosomal disorders, Wong’s innovative approach provides new avenues for addressing complex diseases. His work not only demonstrates his expertise but also his commitment to advancing medical science.

Latest Patents

Li Chin Wong holds a patent that relates to gene therapies aimed at lysosomal disorders. The disclosure outlines compositions and methods for treating diseases associated with aberrant lysosomal function, such as fronto-temporal dementia (FTD). Importantly, the invention includes expression constructs comprising a transgene encoding progranulin or its portions, alongside methods for administering these constructs to patients in need. This patent underscores Wong’s vital contributions to medicine and highlights the potential for transformative treatments.

Career Highlights

Currently, Wong is associated with Prevail Therapeutics, Inc., where he continues his pioneering research. His work at the company solidifies its mission to develop breakthrough therapies for neurodegenerative diseases. Wong’s career is marked by his dedication to improving the lives of those affected by lysosomal dysfunctions.

Collaborations

Throughout his career, Li Chin Wong has collaborated with esteemed colleagues, such as Asa Abeliovich and Laura Heckman. These partnerships emphasize the importance of teamwork in advancing scientific research and enhancing the impact of innovative therapies. Together, they push the boundaries of knowledge and contribute significantly to the medical field.

Conclusion

Li Chin Wong's inventive work in gene therapy highlights his role as a key player in the fight against lysosomal disorders. With one patent under his name and a dedicated career at Prevail Therapeutics, he exemplifies the innovative spirit that drives progress in medicine. His collaborations and contributions pave the way for future advancements, showcasing the potential for innovative treatments that can change lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…